Sensitive and quantitative detection of botulinum neurotoxin in neurons derived from mouse embryonic stem cells

Biochemical and Biophysical Research Communications

Volumn 404, Issue 1, 2011, Pages 388-392

  Pellett, Sabine ^a   Du, Zhong wei ^b   Pier, Christina L ^a   Tepp, William H ^a   Zhang, Su chun ^b   Johnson, Eric A ^a  

^a UNIVERSITY OF WISCONSIN MADISON   (United States)

^b UNIVERSITY OF WISCONSIN MADISON   (United States)

Author keywords

BoNT; Botulinum toxin; Cell assay; MES; Mouse embryonic stem cells

Indexed keywords

BOTULINUM TOXIN A; BOTULINUM TOXIN E;

ANIMAL CELL; ANIMAL EXPERIMENT; ARTICLE; BIOASSAY; BIOLOGICAL ACTIVITY; CELL ASSAY; CONTROLLED STUDY; EMBRYO; EMBRYONIC STEM CELL; FOOD AND DRUG ADMINISTRATION; MOUSE; NERVE CELL; NERVE CELL CULTURE; NONHUMAN; PRIORITY JOURNAL; SENSITIVITY ANALYSIS; TOXIN ANALYSIS; UNITED STATES;

ANIMALS; BIOLOGICAL ASSAY; BIOTERRORISM; BOTULINUM TOXINS, TYPE A; CELL COUNT; CELL CULTURE TECHNIQUES; CELLS, CULTURED; EMBRYONIC STEM CELLS; MICE; NEUROGENESIS; NEURONS; SENSITIVITY AND SPECIFICITY;

EID: 78650870674     PISSN: 0006291X     EISSN: 10902104     Source Type: Journal    
DOI: 10.1016/j.bbrc.2010.11.128     Document Type: Article

References (42)

1. E. 'Johnson, Clostridium botulinum and Clostridium tetani, in: S. P. Borriello, P. R. Murray, and G. Funke (Eds.), Topley and Wilson's Microbiology and Microbial Infections, 8th ed., Hodder Arnold, London, United Kingdom, 2005, pp. 1035-1088.
2. Montecucco C., Molgo J. Botulinal neurotoxins: revival of an old killer. Curr. Opin. Pharmacol. 2005, 5:274-279.
3. Johnson E.A., Montecucco C. Botulism. Engel Handbook of Clinical Neurology 2008, 333-368. Elsevier, (Chapter 11). G. Andrew (Ed.).
4. Arnon S.S., Schechter R., Inglesby T.V., Henderson D.A., Bartlett J.G., Ascher M.S., Eitzen E., Fine A.D., Hauer J., Layton M., Lillibridge S., Osterholm M.T., O'Toole T., Parker G., Perl T.M., Russell P.K., Swerdlow D.L., Tonat K. Botulinum toxin as a biological weapon: medical and public health management. JAMA 2001, 285:1059-1070. Working Group on Civilian Biodefense.
5. Chaddock J.A., Marks P.M. Clostridial neurotoxins: structure-function led design of new therapeutics. Cell Mol. Life Sci. 2006, 63:540-551.
6. Foster K.A., Bigalke H., Aoki K.R. Botulinum neurotoxin - from laboratory to bedside. Neurotox. Res. 2006, 9:133-140.
7. Peck M.W. Biology and genomic analysis of Clostridium botulinum. Adv. Microb. Physiol. 2009, 55:183-265. 320.
8. Gimenez D.F., Gimenez J.A. The typing of botulinal neurotoxins. Int. J. Food Microbiol. 1995, 27:1-9.
9. Montal M. Botulinum neurotoxin: a marvel of protein design. Annu. Rev. Biochem. 2010, 79:591-617.
10. Montecucco C. How do tetanus and botulinum toxins bind to neuronal membranes?. Trends Biochem. Sci. 1986, 11:314-317.
11. Montecucco C., Rossetto O., Schiavo G. Presynaptic receptor arrays for clostridial neurotoxins. Trends Microbiol. 2004, 12:442-446.
12. Fischer A., Montal M. Crucial role of the disulfide bridge between botulinum neurotoxin light and heavy chains in protease translocation across membranes. J. Biol. Chem. 2007, 282:29604-29611.
13. Fischer A., Montal M. Single molecule detection of intermediates during botulinum neurotoxin translocation across membranes. Proc. Natl. Acad. Sci. USA 2007, 104:10447-10452.
14. Montecucco C., Schiavo G. Mechanism of action of tetanus and botulinum neurotoxins. Mol. Microbiol. 1994, 13:1-8.
15. Schiavo G., Rossetto O., Tonello F., Montecucco C. Intracellular targets and metalloprotease activity of tetanus and botulism neurotoxins. Curr. Top. Microbiol. Immunol. 1995, 195:257-274.
16. Jena B.P. Membrane fusion: role of SNAREs and calcium. Protein Pept. Lett. 2009, 16:712-717.
17. Binz T., Blasi J., Yamasaki S., Baumeister A., Link E., Sudhof T.C., Jahn R., Niemann H. Proteolysis of SNAP-25 by types E and A botulinal neurotoxins. J. Biol. Chem. 1994, 269:1617-1620.
18. Blasi J., Chapman E.R., Link E., Binz T., Yamasaki S., De Camilli P., Sudhof T.C., Niemann H., Jahn R. Botulinum neurotoxin A selectively cleaves the synaptic protein SNAP-25. Nature 1993, 365:160-163.
19. Yamasaki S., Baumeister A., Binz T., Blasi J., Link E., Cornille F., Roques B., Fykse E.M., Sudhof T.C., Jahn R. Cleavage of members of the synaptobrevin/VAMP family by types D and F botulinal neurotoxins and tetanus toxin. J. Biol. Chem. 1994, 269:12764-12772.
20. Schiavo G., Shone C.C., Rossetto O., Alexander F.C., Montecucco C. Botulinum neurotoxin serotype F is a zinc endopeptidase specific for VAMP/synaptobrevin. J. Biol. Chem. 1993, 268:11516-11519.
21. Schiavo G., Benfenati F., Poulain B., Rossetto O., Polverino de Laureto P., DasGupta B.R., Montecucco C. Tetanus and botulinum-B neurotoxins block neurotransmitter release by proteolytic cleavage of synaptobrevin. Nature 1992, 359:832-835.
22. C.L. Hatheway, Botulism, in: Anonymous, 1988, pp. 111-133.
23. Schantz E.J., Kautter D.A. Standardized assay for Clostridium botulinum toxins. J. Assoc. Off. Anal. Chem. 1978, 61:96-99.
24. Hakami R.M., Ruthel G., Stahl A.M., Bavari S. Gaining ground: assays for therapeutics against botulinum neurotoxin. Trends Microbiol. 2010, 18:164-172.
25. Lindstrom M., Korkeala H. Laboratory diagnostics of botulism. Clin. Microbiol. Rev. 2006, 19:298-314.
26. Pellett S., Tepp W.H., Clancy C.M., Borodic G.E., Johnson E.A. A neuronal cell-based botulinum neurotoxin assay for highly sensitive and specific detection of neutralizing serum antibodies. FEBS Lett. 2007, 581:4803-4808.
27. S. Pellett, W.H. Tepp, S.I. Toth, E.A. Johnson, Comparison of the primary rat spinal cord cell (RSC) assay and the mouse bioassay for botulinum neurotoxin type A potency determination, J. Pharmacol. Toxicol. Methods (2010).
28. Nuss J.E., Ruthel G., Tressler L.E., Wanner L.M., Torres-Melendez E., Hale M.L., Bavari S. Development of cell-based assays to measure botulinum neurotoxin serotype A activity using cleavage-sensitive antibodies. J. Biomol. Screen. 2010, 15:42-51.
29. Lee S.K., Jurata L.W., Funahashi J., Ruiz E.C., Pfaff S.L. Analysis of embryonic motoneuron gene regulation: derepression of general activators function in concert with enhancer factors. Development 2004, 131:3295-3306.
30. Zhang S.C. Neural subtype specification from embryonic stem cells. Brain Pathol. 2006, 16:132-142.
31. H. Wichterle, M. Peljto, Differentiation of mouse embryonic stem cells to spinal motor neurons, Curr. Protoc. Stem Cell. Biol. (2008) Unit 1H.1.1-1H.1.9 (Chapter 1).
32. Du Z.W., Li X.J., Nguyen G.D., Zhang S.C. Induced expression of Olig2 is sufficient for oligodendrocyte specification but not for motoneuron specification and astrocyte repression. Mol. Cell Neurosci. 2006, 33:371-380.
33. Wichterle H., Lieberam I., Porter J.A., Jessell T.M. Directed differentiation of embryonic stem cells into motor neurons. Cell 2002, 110:385-397.
34. Malizio C.J., Goodnough M.C., Johnson E.A. Purification of Clostridium botulinum type A neurotoxin. Methods Mol. Biol. 2000, 145:27-39.
35. Prabakaran S., Tepp W., DasGupta B.R. Botulinum neurotoxin types B and E: purification, limited proteolysis by endoproteinase Glu-C and pepsin, and comparison of their identified cleaved sites relative to the three-dimensional structure of type A neurotoxin. Toxicon 2001, 39:1515-1531.
36. Rohwedel J., Guan K., Wobus A.M. Induction of cellular differentiation by retinoic acid in vitro. Cells Tissues Organs 1999, 165:190-202.
37. Li X.J., Hu B.Y., Jones S.A., Zhang Y.S., Lavaute T., Du Z.W., Zhang S.C. Directed differentiation of ventral spinal progenitors and motor neurons from human embryonic stem cells by small molecules. Stem Cells 2008, 26:886-893.
38. Winkler J., Sotiriadou I., Chen S., Hescheler J., Sachinidis A. The potential of embryonic stem cells combined with -omics technologies as model systems for toxicology. Curr. Med. Chem. 2009, 16:4814-4827.
39. Breier J.M., Gassmann K., Kayser R., Stegeman H., De Groot D., Fritsche E., Shafer T.J. Neural progenitor cells as models for high-throughput screens of developmental neurotoxicity: state of the science. Neurotoxicol. Teratol. 2010, 32:4-15.
40. Li X.J., Du Z.W., Zarnowska E.D., Pankratz M., Hansen L.O., Pearce R.A., Zhang S.C. Specification of motoneurons from human embryonic stem cells. Nat. Biotechnol. 2005, 23:215-221.
41. Jessell T.M. Neuronal specification in the spinal cord: inductive signals and transcriptional codes. Nat. Rev. Genet. 2000, 1:20-29.
42. Keller J.E., Cai F., Neale E.A. Uptake of botulinum neurotoxin into cultured neurons. Biochemistry 2004, 43:526-532.